Core Viewpoint - Sipai Health (00314.HK) has been actively repurchasing its shares, indicating a strong commitment to enhancing shareholder value through buybacks [1][2] Group 1: Share Buyback Details - The company repurchased 1.239 million shares on January 14 at prices ranging from HKD 2.710 to HKD 2.890, totaling HKD 3.5034 million [1] - Since January 9, the company has conducted buybacks for four consecutive days, acquiring a total of 3.3902 million shares for a cumulative amount of HKD 9.4843 million [1] - The stock price increased by 2.89% during this buyback period, closing at HKD 2.850 on January 14 [1] Group 2: Year-to-Date Buyback Summary - Year-to-date, the company has completed seven buyback transactions, acquiring a total of 4.0626 million shares for a total expenditure of HKD 11.1421 million [2] - The buyback details include the highest and lowest prices for each transaction, with the most recent buyback on January 14 showing a maximum price of HKD 2.890 and a minimum of HKD 2.710 [2] - The cumulative buyback activity reflects the company's strategy to support its stock price and return capital to shareholders [2]
思派健康(00314.HK)连续4日回购，累计斥资948.43万港元